Pharmaceutical Market Access in Emerging Markets
This comprehensive resource examines pharmaceutical market access strategies specifically designed for emerging markets, where growth rates significantly outpace developed nations. With a Compounded Average Growth Rate (CAGR) of 6.0% between 2011-2017 and expected sales exceeding 1.1 trillion USD by 2017, emerging countries represent critical opportunities for pharmaceutical companies launching new products.
Market Access Beyond Authorization
Market access encompasses more than simple market authorization. This book defines pharmaceutical market access as achieving optimal pricing for products or services and maximum reimbursement for approved target populations without funding restrictions on medical technology. The comprehensive approach covers overlapping activities including pricing strategies, health technology assessment, formulary management, and reimbursement processes.
Growth Opportunities in Emerging Markets
The data demonstrates compelling opportunities: recently launched pharmaceuticals showed a CAGR of 9.8% in emerging countries compared to just 1.5% in the top 8 developed countries between 2008-2012. This substantial difference highlights why pharmaceutical companies prioritize market access strategies in these regions.
Comprehensive Regional Coverage
This resource maps market access processes across the most important emerging countries in selected regions. Each country profile includes healthcare system structures, health policy pathways, decision-maker hierarchies, and specific market access challenges and catalyzers unique to that region.
Practical Applications
Designed for local healthcare experts, government officers, headquarter management teams, and professionals seeking deeper understanding of healthcare systems and health policies. The book provides actionable frameworks for navigating complex regulatory environments, understanding reimbursement mechanisms, and identifying key stakeholders in each market.
Authors: Albert Wertheimer and Guvenc Kockaya
Published by Independently Published in November 2017, this paperback delivers practical insights drawn from real-world market access experiences. The authors combine theoretical frameworks with practical implementation strategies to help readers understand the nuances of pharmaceutical market access in diverse emerging market environments.
Whether you're developing market entry strategies, negotiating pricing agreements, or navigating health technology assessment processes, this resource provides the foundational knowledge needed to succeed in emerging pharmaceutical markets.
